Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:28 AM
Ignite Modification Date:
2025-12-25 @ 2:28 AM
NCT ID:
NCT00726934
Eligibility Criteria:
Inclusion Criteria:
1. Patients between the ages of 1 and 30 years with:
* Acute lymphoblastic leukemia/lymphoma
* Malignant brain tumor
* Non-CNS solid tumors
* Acute myeloblastic leukemia
* Non-Hodgkin's lymphoma Hodgkin's disease
* Head and Neck tumors
2. Patients MUST also be ready to receive a cycle of chemotherapy that predictably renders neutropenia at least 70% of the time OR has a risk of febrile neutropenia of at least 20%. This can be any cycle number, it does NOT need to be the FIRST cycle of chemotherapy they are to receive.
Exclusion Criteria:
* Patients receiving myeloablative chemotherapy in preparation for allogeneic or autologous bone marrow or stem cell transplant.
* Co-morbidity with immunosuppressive disease such as AIDS.
* Asplenia.
* Patients with documented infection at time of enrollment.
* Patients who are not fed orally (G-tube dependant, TPN-dependant).
* Patients actively receiving radiation to the brain or gastrointestinal tract for sarcoma.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Year
Maximum Age:
30 Years
Study:
NCT00726934
Study Brief:
Protocol Section:
NCT00726934